---
figid: PMC5709276__nihms880760f1
figlink: /pmc/articles/PMC5709276/figure/F1/
number: F1
caption: 'Pathway alterations in glioblastoma multiforme. Canonical signaling pathway
  and tumor suppressor pathways are summarized for glioblastoma, highlighting potential
  nodes of convergence amenable to blockade by experimental therapeutics as monotherapy
  or in combination with radiation therapy. Percentages represent the proportion of
  glioblastoma cases harboring amplification (+) or mutation or homozygous deletion
  (−) of indicated pathway node. Figure adapted from reference []. Abbreviations:
  EGFR = epidermal growth factor receptor, PDGFT = platelet-derived growth factor
  receptor, c-MET = hepatocyte growth factor receptor, FGFR = fibroblast growth factor
  receptor, PTEN = phosphatase and tensin homolog, PI3K = phosphoinositide 3-kinase,
  NF1 = neurofibromatosis type 1, Akt = protein kinase B, mTOR = mammalian target
  of rapamycin, MAPK = mitogen-activated protein kinase, MDM2 = mouse double minute
  2 homolog, CDK = cyclin-dependent kinase, RNR = ribonucleotide reductase, Rb = retinoblastoma
  protein.'
pmcid: PMC5709276
papertitle: 'Radiation-agent combinations for glioblastoma: challenges in drug development
  and future considerations.'
reftext: Charles A. Kunos, et al. J Neurooncol. ;134(3):551-557.
pmc_ranked_result_index: '48390'
pathway_score: 0.7858
filename: nihms880760f1.jpg
figtitle: Pathway alterations in glioblastoma multiforme
year: ''
organisms:
- Homo sapiens
ndex: c6898ad2-df28-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5709276__nihms880760f1.html
  '@type': Dataset
  description: 'Pathway alterations in glioblastoma multiforme. Canonical signaling
    pathway and tumor suppressor pathways are summarized for glioblastoma, highlighting
    potential nodes of convergence amenable to blockade by experimental therapeutics
    as monotherapy or in combination with radiation therapy. Percentages represent
    the proportion of glioblastoma cases harboring amplification (+) or mutation or
    homozygous deletion (−) of indicated pathway node. Figure adapted from reference
    []. Abbreviations: EGFR = epidermal growth factor receptor, PDGFT = platelet-derived
    growth factor receptor, c-MET = hepatocyte growth factor receptor, FGFR = fibroblast
    growth factor receptor, PTEN = phosphatase and tensin homolog, PI3K = phosphoinositide
    3-kinase, NF1 = neurofibromatosis type 1, Akt = protein kinase B, mTOR = mammalian
    target of rapamycin, MAPK = mitogen-activated protein kinase, MDM2 = mouse double
    minute 2 homolog, CDK = cyclin-dependent kinase, RNR = ribonucleotide reductase,
    Rb = retinoblastoma protein.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - EGFR
  - FGFR1
  - FGFRL1
  - MAPK14
  - CDKN2B
  - MAPK13
  - FGFR2
  - MDM4
  - MTOR
  - MAPK12
  - FGFR4
  - CDKN2A
  - PIK3CG
  - NF1
  - FGFR3
  - MDM2
  - NRAS
  - PIK3R3
  - PTEN
  - PIK3CB
  - TP53
  - HRAS
  - KRAS
  - MAPK9
  - PIK3CD
  - CDK6
  - MAPK11
  - PIK3R6
  - MAPK10
  - MAPK3
  - PIK3R5
  - CDK4
  - MAPK1
  - PIK3R4
  - MAPK8
  - AKT3
  - AKT1
  - PIK3CA
  - BRAF
  - AKT2
  - Cancer
  - Lung cancer
  - Melanoma
genes:
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR1
  entrez: '2260'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFRL1
  entrez: '53834'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: CDKN2B
  symbol: CDKN2B
  source: hgnc_symbol
  hgnc_symbol: CDKN2B
  entrez: '1030'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR2
  entrez: '2263'
- word: MDM4
  symbol: MDM4
  source: hgnc_symbol
  hgnc_symbol: MDM4
  entrez: '4194'
- word: mTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR4
  entrez: '2264'
- word: CDKN2A
  symbol: CDKN2A
  source: hgnc_symbol
  hgnc_symbol: CDKN2A
  entrez: '1029'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: NF1
  symbol: NF1
  source: hgnc_symbol
  hgnc_symbol: NF1
  entrez: '4763'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR3
  entrez: '2261'
- word: MDM2
  symbol: MDM2
  source: hgnc_symbol
  hgnc_symbol: MDM2
  entrez: '4193'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: p53
  symbol: p53
  source: hgnc_alias_symbol
  hgnc_symbol: TP53
  entrez: '7157'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: CDK6
  symbol: CDK6
  source: hgnc_symbol
  hgnc_symbol: CDK6
  entrez: '1021'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: CDK4
  symbol: CDK4
  source: hgnc_symbol
  hgnc_symbol: CDK4
  entrez: '1019'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: BRAF
  symbol: BRAF
  source: hgnc_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Melanoma
  source: ''
  identifier: ''
figid_alias: PMC5709276__F1
redirect_from: /figures/PMC5709276__F1
figtype: Figure
---
